{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:07:00Z","timestamp":1783404420863,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1017\/s104161021900111x","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T08:17:28Z","timestamp":1571732248000},"page":"315-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The \u201cCHROME criteria\u201d: Tool to optimize and audit prescription quality of psychotropic medications in institutionalized people with dementia"],"prefix":"10.1016","volume":"32","author":[{"given":"Ruben","family":"Mu\u00f1iz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia I.","family":"P\u00e9rez-Wehbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Usieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lietzan","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rigueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ag\u00fcera-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"L\u00f3pez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mart\u00edn-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Olazar\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S104161021900111X_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1017\/S104161021900111X_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cali.2015.04.003","article-title":"Consequences of errors in the translation of questionnaires: Spanish version of Downton index","volume":"30","author":"Aranda-Gallardo","year":"2015","journal-title":"Revista de Calidad Asistencial"},{"key":"10.1017\/S104161021900111X_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","article-title":"The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial","volume":"8","author":"Ballard","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1017\/S104161021900111X_bb0025","doi-asserted-by":"crossref","unstructured":"R. E. Brimelow J. A. Wollin G. J. Byrne N. N. Dissanayaka , , and (in press). Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia. International Psychogeriatrics, 31, 837\u2013847. doi: 10.1017\/S1041610218001229.","DOI":"10.1017\/S1041610218001229"},{"key":"10.1017\/S104161021900111X_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/S1135-57271997000200004","article-title":"Disability evaluation: Barthel\u2019s index","volume":"71","author":"Cid-Ruzafa","year":"1997","journal-title":"Revista Espa\u00f1ola de Salud P\u00fablica"},{"key":"10.1017\/S104161021900111X_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jad.2018.04.015","article-title":"The course of anxiety in persons with dementia in Norwegian nursing homes: a 12-month follow-up study","volume":"235","author":"Goyal","year":"2018","journal-title":"Journal of Affective Disorders"},{"key":"10.1017\/S104161021900111X_bb0040","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00002512-200522040-00006","article-title":"Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?","volume":"22","author":"Hughes","year":"2005","journal-title":"Drugs & Aging"},{"key":"10.1017\/S104161021900111X_bb0045","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S1041610216001150","article-title":"Psychotropic drug prescriptions in Western European nursing homes","volume":"28","author":"Janus","year":"2016","journal-title":"International Psychogeriatrics"},{"issue":"Suppl 2","key":"10.1017\/S104161021900111X_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ageing\/26.suppl_2.43","article-title":"Comparisons of restraint use in nursing homes in eight countries","volume":"26","author":"Ljunggren","year":"1997","journal-title":"Age & Ageing"},{"key":"10.1017\/S104161021900111X_bb0055","first-page":"767","article-title":"[Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population]","volume":"112","author":"Lobo","year":"1999","journal-title":"Medicina Cl\u00ednica (Barcelona)"},{"key":"10.1017\/S104161021900111X_bb0060","first-page":"320","article-title":"The pharmacotherapy of neuropsychiatric symptoms of dementia: a cross-sectional study in 18 homes for the elderly in Berlin","volume":"107","author":"Majic","year":"2010","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1017\/S104161021900111X_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12877-018-1015-9","article-title":"Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients","volume":"19","author":"Massot Mesquida","year":"2019","journal-title":"BMC Geriatrics"},{"key":"10.1017\/S104161021900111X_bb0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jamda.2016.03.011","article-title":"Reducing physical restraints in nursing homes: A report from Maria Wolff and Sanitas","volume":"17","author":"Mu\u00f1iz","year":"2016","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S104161021900111X_bb0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3233\/JAD-160828","article-title":"Psychotropic polypharmacy in patients with dementia: prevalence and predictors","volume":"56","author":"N\u00f8rgaard","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1017\/S104161021900111X_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jamda.2012.10.020","article-title":"Psychotropic medications and falls in nursing homes: a cross-sectional study","volume":"14","author":"Olazar\u00e1n","year":"2013","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S104161021900111X_bb0085","first-page":"91","article-title":"[The CHROME criteria for the accreditation of centers free of chemical restraints and for a quality prescription of psychotropic medications]","volume":"6","author":"Olazar\u00e1n-Rodr\u00edguez","year":"2016","journal-title":"Psicogeriatr\u00eda"},{"key":"10.1017\/S104161021900111X_bb0090","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2105\/AJPH.90.1.92","article-title":"Use of physical restraints and psychotropic medications in Alzheimer special care units in nursing homes","volume":"90","author":"Phillips","year":"2000","journal-title":"American Journal of Public Health"},{"key":"10.1017\/S104161021900111X_bb0095","doi-asserted-by":"crossref","first-page":"187.e7","DOI":"10.1016\/j.jamda.2011.03.007","article-title":"Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of three cohorts","volume":"13","author":"Richter","year":"2012","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S104161021900111X_bb0100","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"Journal of the American Medical Association"},{"key":"10.1017\/S104161021900111X_bb0105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S1041610210000608","article-title":"Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review","volume":"22","author":"Seitz","year":"2010","journal-title":"International Psychogeriatrics"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224024773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224024773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S104161021900111X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T17:50:46Z","timestamp":1744393846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224024773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1041610224024773"],"URL":"https:\/\/doi.org\/10.1017\/s104161021900111x","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u201cCHROME criteria\u201d: Tool to optimize and audit prescription quality of psychotropic medications in institutionalized people with dementia","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S104161021900111X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}